This information is part of the 2018 NMJ Oncology Special problem. Grab the full problem here.
Resource
Johnson SB, Park HS, Gross CP, Yu JB. Subservient medication, refusal of main-stream malignant tumors treatments, and success among people with treatable cancers. JAMA Oncol. 2018;4(10):1375-1381.
Concept
A retrospective observational review of information obtained from the National Cancer Database (NCDB)
Members
The first cohort provided 1,901,815 customers who were identified as having non-metastatic breasts, prostate, lung, or colorectal cancer tumors between 2004 and 2013. Continue reading “Really does Subsidiary Medicine Boost Danger Of Death for Cancer Tumors Clients?”